Found: 9
Select item for more details and to access through your institution.
Cardiometabolic risk reductions in patients with type 2 diabetes mellitus newly treated with a sodium–glucose cotransporter 2 inhibitor versus a dipeptidyl peptidase‐4 inhibitor: A real‐world administrative database study in Japan
- Published in:
- Journal of Diabetes Investigation, 2023, v. 14, n. 3, p. 404, doi. 10.1111/jdi.13952
- By:
- Publication type:
- Article
Strategies for handling normality assumptions in multi-level modeling: A case study estimating trajectories of Health Utilities Index Mark 3 scores.
- Published in:
- 2011
- By:
- Publication type:
- Case Study
CANADIAN CANCER RISK MANAGEMENT MODEL: EVALUATION OF CANCER CONTROL.
- Published in:
- International Journal of Technology Assessment in Health Care, 2013, v. 29, n. 2, p. 131, doi. 10.1017/S0266462313000044
- By:
- Publication type:
- Article
Comparative effectiveness of sodium‐glucose co‐transporter‐2 inhibitors and dipeptidyl peptidase‐4 inhibitors on liver function in patients with type 2 diabetes in Japan: A real‐world data analysis.
- Published in:
- Diabetes, Obesity & Metabolism, 2024, v. 26, n. 3, p. 997, doi. 10.1111/dom.15399
- By:
- Publication type:
- Article
Health-related quality of life with enzalutamide versus flutamide in castration-resistant prostate cancer from the AFTERCAB study.
- Published in:
- International Journal of Clinical Oncology, 2022, v. 27, n. 10, p. 1632, doi. 10.1007/s10147-022-02221-w
- By:
- Publication type:
- Article
The OncoSim-Breast Cancer Microsimulation Model.
- Published in:
- Current Oncology, 2022, v. 29, n. 3, p. 1619, doi. 10.3390/curroncol29030136
- By:
- Publication type:
- Article
Real‐world epidemiology and treatment patterns of patients with locally advanced or metastatic urothelial carcinoma: Retrospective analysis of Diagnosis Procedure Combination claims data in Japan.
- Published in:
- International Journal of Urology, 2024, v. 31, n. 7, p. 730, doi. 10.1111/iju.15450
- By:
- Publication type:
- Article
Estimates of future cancer mortality attributable to modifiable risk factors in Canada.
- Published in:
- Canadian Journal of Public Health, 2021, v. 112, n. 6, p. 1069, doi. 10.17269/s41997-020-00455-7
- By:
- Publication type:
- Article
Estimating the future cancer management costs attributable to modifiable risk factors in Canada.
- Published in:
- Canadian Journal of Public Health, 2021, v. 112, n. 6, p. 1083, doi. 10.17269/s41997-021-00502-x
- By:
- Publication type:
- Article